1389-4501
Bimonthly
No
CURR DRUG TARGETS
2000
161
NETHERLANDS
http://benthamscience.com/journal/index.php?journalID=cdt
一般,3-8周审稿时间
较难平均录用比例
2.5影响因子
药学小学科
181/352JIF RANK
6259总被引频次
月期刊平台服务过的文章录用时间为1-3个月,依据20年经验,经月期刊专家预审通过后的文章,投稿通过率100%以上!
由边沁科学出版社出版。ISSN: 1389 - 4501。目前的药物靶标旨在涵盖药物化学和分子药物靶标(如疾病特异性蛋白、受体、酶、基因)药理方面所有最新和杰出的进展。该杂志的每一期都将包含一系列由该领域的领导人及时撰写的深入评论,涵盖当前有关药物靶标的一系列主题。随着用于药物发现的新型人类药物靶点的发现、鉴定、表征和验证的不断发展;这本杂志将是所有参与药物发现和开发的药物学家的必读书。
http://bsp-cms.eurekaselect.com/index.php/CDT
Published by Bentham Science Publishers. ISSN: 1389-4501.Current Drug Targets aims to cover all the latest and outstanding developments on the medicinal chemistry and pharmacology of molecular drug targets e.g. disease specific proteins, receptors, enzymes, genes. Each issue of the journal will contain a series of timely in-depth reviews written by leaders in the field covering a range of current topics on drug targets. As the discovery, identification, characterisation and validation of novel human drug targets for drug discovery continues to grow; this journal will be essential reading for all pharmaceutical scientists involved in drug discovery and development.